Dashboard
Manage Tickers

PPBT PURPLE BIOTECH LTD.

Nasdaq purple-biotech.com


$ 0.79 $ -0.15 (-16.47 %)    

Friday, 31-Oct-2025 18:21:44 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 0.7851
$ 0.88
$ 0.75 x 150
$ 0.86 x 888
$ 0.75 - $ 0.91
$ 0.53 - $ 13.95
3,703,528
na
990,715
$ 0.86
$ 0.09
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/30/2025 12:08:54

why-alphabet-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket
Why Alphabet Shares Are Trading Higher By ...
10/30/2025 09:38:55

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/29/2025 17:06:03

dow-surges-250-points-verizon-posts-mixed-q3-results
Dow Surges 250 Points; Verizon Posts Mixed...
10/29/2025 13:57:56

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/29/2025 12:06:08

purple-biotech--achieved-commercial-viable-yield-for-im1240
Purple Biotech Achieved Commercial Viable...
10/29/2025 11:33:45

purple-biotech-receives-nasdaq-non-compliance-notice
Purple Biotech Receives Nasdaq Non-Complia...
10/20/2025 20:01:18

purple-biotech-says-eu-patent-office-issues-intention-to-grant-european-patent-for-combinations-of-irsstat3-dual-modulators-and-anti-cancer-agents-for-treating-cancer
Purple Biotech Says EU Patent Office Issue...
09/10/2025 12:07:54

A Phase 2 study for NT219 in combination with immunotherapy is being conducted in collaboration with the University of Colorado...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
09/05/2025 17:06:13

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/04/2025 17:05:59

purple-biotech-prices-6m-public-offering-of-6m-adss-or-pre-funded-warrants-at-a-combined-price-of-100-short-term-warrants-to-purchase-up-to-12m-adss-at-100-for-up-to-12m-in-potential-additional-proceeds
Purple Biotech Prices $6M Public Offering ...
09/04/2025 13:19:00

$6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of shor...

purple-biotech-unveils-cancer-data-on-new-tri-specific-antibody-im1240
Purple Biotech Unveils Cancer Data On New ...
09/04/2025 11:18:32

Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developin...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/03/2025 12:08:15

purple-biotech-announced-its-second-captn-3-trispecific-antibody-im1305-targeting-trop2-in-development-fda-investigational-new-drug-submission-planned-for-2026
Purple Biotech Announced Its Second CAPTN-...
09/03/2025 11:14:15

IM1305 (capped-CD3xTROP2xNKG2A) contains a masked anti-CD3 arm, as well as an anti-NKG2A arm, and an anti-TROP2 arm. The potent...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/02/2025 17:06:49

purple-biotech-q2-eps-040-beats-062-estimate
Purple Biotech Q2 EPS $(0.40) Beats $(0.62...
08/06/2025 11:17:47

purple-biotechs-chief-executive-officer-gil-efron-issued-a-letter-to-shareholders-highlighting-the-companys-scientific-progress-operational-execution-and-strategic-milestones-during-1h-2025
Purple Biotech's Chief Executive Officer G...
07/24/2025 11:29:42

2025 First Half HighlightsCM24 (α-CEACAM1 monoclonal antibody)Our Phase 2 dataset demonstrated strong objective response rates ...

purple-biotech-presents-new-preclinical-data-on-captn-3-tri-specific-antibody-platform-at-eacr-2025
Purple Biotech Presents New Preclinical Da...
06/23/2025 11:06:10

Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developin...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
06/18/2025 21:05:53

purple-biotech-initiated-phase-2-study-evaluating-nt219-in-patients-with-recurrent-andor-metastatic-squamous-cell-carcinoma-of-the-head-and-neck
Purple Biotech Initiated Phase 2 Study Eva...
06/17/2025 11:05:00

NT219 is a novel small molecule designed to target two key oncogenic pathways: IRS1/2 (Insulin Receptor Substrates 1 and 2) and...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION